Sign In
Buy CERS
$2.66
-0.0400 (-1.48%)
At Close: Jun 03, 2026
Cerus Target of Unusually High Options Trading (NASDAQ:CERS)
05:42am, Sunday, 26'th Apr 2020
Cerus Co. (NASDAQ:CERS) saw unusually large options trading activity on Friday. Stock traders purchased 5,369 call options on the stock. This is an increase of 891% compared to the typical daily volum
How Much is Cerus Corporation’s (NASDAQ:CERS) CEO Getting Paid?
01:29pm, Saturday, 25'th Apr 2020
Obi Greenman became the CEO of Cerus Corporation (NASDAQ:CERS) in 2011. This report will, first, examine the CEO...
Cerus Corporation to Release First Quarter 2020 Financial Results on May 5, 2020
12:30pm, Friday, 24'th Apr 2020
Cerus Corporation (Nasdaq:CERS) announced today that its first quarter 2020 financial results will be released on Tuesday, May 5, 2020, after the close of the stock market. The Company will host a con
Cerus Corporation (CERS) Shares March Higher, Can It Continue?
03:43pm, Thursday, 23'rd Apr 2020
As of late, it has definitely been a great time to be an investor in Cerus Corporation (CERS).
Cerus Corporation (CERS) Shares March Higher, Can It Continue?
03:43pm, Thursday, 23'rd Apr 2020
As of late, it has definitely been a great time to be an investor in Cerus Corporation (CERS).
Cerus Corporation (CERS) Shares March Higher, Can It Continue?
12:00am, Thursday, 23'rd Apr 2020Cerus Endovascular Receives CE Mark Approvals for its Neqstent™ Coil Assisted Flow Diverter Designed to Treat Intracranial Aneurysms
10:33am, Wednesday, 22'nd Apr 2020
Cerus Endovascular Ltd., a privately-held, commercial stage medical device company, today announced that it has received CE Mark approval for its Neqstent™ Coil Assisted Flow Diverter device, design
Zacks Investment Research Upgrades Cerus (NASDAQ:CERS) to Buy
05:48am, Wednesday, 22'nd Apr 2020
Cerus (NASDAQ:CERS) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued to investors on Monday, Zacks.com reports. The brokerage presentl
The Daily Biotech Pulse: Applied DNA Begins Validating COVID-19 Test, Cara's Positive Readout, Novan Explores Strategic Alternatives
12:19pm, Tuesday, 21'st Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs April 20) * Abbott Laboratories (NYSE: ABT) * Acceleron Phar
Cerus expands BARDA funding by additional $14M
12:02pm, Tuesday, 21'st Apr 2020
Cerus (NASDAQ:CERS) amends its contract with the Biomedical Advanced Research and Development Authority (BARDA).The amendment provides an additional $14M in available funding, increasing the
The Daily Biotech Pulse: Applied DNA Begins Validating COVID-19 Test, Cara's Positive Readout, Novan Explores Strategic Alternatives
12:00am, Tuesday, 21'st Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs April 20)
Abbott Laboratories (NYSE...
Cerus Corporation Announces Expansion of BARDA Funding to Support Development of INTERCEPT Blood System for Red Blood Cells
09:50pm, Monday, 20'th Apr 2020
Cerus Corporation (Nasdaq:CERS) today announced an amendment to the Company’s contract with the Biomedical Advanced Research and Development Authority (BARDA). The amendment provides an additional $
Cerus announces expansion of BARDA funding CERS
10:51am, Monday, 20'th Apr 2020
Cerus announces expansion of BARDA funding CERS
Bank of New York Mellon Corp Has $2.50 Million Holdings in Cerus Co. (NASDAQ:CERS)
10:14am, Monday, 20'th Apr 2020
Bank of New York Mellon Corp lifted its stake in shares of Cerus Co. (NASDAQ:CERS) by 2.4% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commiss
